Kazuhisa Matsumoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kazuhisa Matsumoto has a total of 224 co-authors. Here are the top co-authors by number of shared publications:
- Hitoshi Mori
Department of Cardiology Saitama Medical University International Medical Center Hidaka Saitama Japan
23 shared publications - Ritsushi Kato
Department of Cardiology Saitama Medical University, International Medical Center Hidaka Saitama Japan
18 shared publications Naomichi Tanaka
Department of Cardiology Saitama Medical University International Medical Center Hidaka Saitama Japan
17 shared publications- Wataru Sasaki
Department of Cardiology Saitama Medical University, International Medical Center Hidaka Saitama Japan
17 shared publications Yoshifumi Ikeda
Department of Cardiology Saitama Medical University International Medical Center Saitama Japan
16 shared publications- Daisuke Kawano
Department of Cardiology Saitama Medical University International Medical Center Hidaka Saitama Japan
12 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70469
Clinical Characteristics and Timing of Accessory Pathway Reconduction During Catheter Ablation of Accessory Pathways
Background: Catheter ablation of accessory pathways has high acute success rates; however, accessory pathway (AP) recurrence remains a clinically relevant issue. Although intra‐procedural AP reconduction is frequently encountered during ablation procedures, its timing, predictors, and clinical significance remain insufficiently characterized. Objectives: This study aimed to investigate the timing, electrophysiologic characteristics, and clinical implications of intra‐procedural AP reconduction during catheter ablation of manifest and concealed accessory pathways. Methods: We retrospectively analyzed 128 patients with manifest or concealed AP who underwent catheter ablation at our institution between May 28, 2015, and February 2025. Details of cases in which AP reconduction was observed during the 30 min waiting period after successful ablation, including clinical and procedural characteristics, were compared with those of patients without reconduction. Results: Intra‐procedural AP reconduction occurred in 23 patients (18.0%). The mean time to reconduction was 16.7 ± 7.0 min, with a maximum interval of 27 min. Compared with patients without reconduction, those with reconduction had a significantly longer time to pathway interruption, more frequent broad or oblique APs, and more complex procedural approaches requiring multiple anatomical access routes. Intra‐procedural reconduction was also associated with subsequent late recurrence. Fifteen of 23 events (65.2%) occurred ≥ 15 min after AP elimination. Conclusions: Intra‐procedural AP reconduction during catheter ablation of accessory pathways is not uncommon and appears to be associated with specific electrophysiologic and procedural characteristics as well as late recurrence. These findings may facilitate identification of patients at higher risk of reconduction and help guide intra‐procedural assessment during catheter ablation.
- 18 September 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5) , e70469
Open AccessClinical Characteristics and Timing of Accessory Pathway Reconduction During Catheter Ablation of Accessory Pathways
Background: Catheter ablation of accessory pathways has high acute success rates; however, accessory pathway (AP) recurrence remains a clinically relevant issue. Although intra‐procedural AP reconduction is frequently encountered during ablation procedures, its timing, predictors, and clinical significance remain insufficiently characterized. Objectives: This study aimed to investigate the timing, electrophysiologic characteristics, and clinical implications of intra‐procedural AP reconduction during catheter ablation of manifest and concealed accessory pathways. Methods: We retrospectively analyzed 128 patients with manifest or concealed AP who underwent catheter ablation at our institution between May 28, 2015, and February 2025. Details of cases in which AP reconduction was observed during the 30 min waiting period after successful ablation, including clinical and procedural characteristics, were compared with those of patients without reconduction. Results: Intra‐procedural AP reconduction occurred in 23 patients (18.0%). The mean time to reconduction was 16.7 ± 7.0 min, with a maximum interval of 27 min. Compared with patients without reconduction, those with reconduction had a significantly longer time to pathway interruption, more frequent broad or oblique APs, and more complex procedural approaches requiring multiple anatomical access routes. Intra‐procedural reconduction was also associated with subsequent late recurrence. Fifteen of 23 events (65.2%) occurred ≥ 15 min after AP elimination. Conclusions: Intra‐procedural AP reconduction during catheter ablation of accessory pathways is not uncommon and appears to be associated with specific electrophysiologic and procedural characteristics as well as late recurrence. These findings may facilitate identification of patients at higher risk of reconduction and help guide intra‐procedural assessment during catheter ablation.
- 1 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2241-2250
Accurate Diagnosis of Atrioventricular Nodal Reentrant Tachycardia With Very Short His‐Atrial Interval and Earliest Activation in the Proximal Coronary Sinus
Introduction: Differential diagnoses in atrioventricular nodal reentrant tachycardia (AVNRT) with His‐atrial (HA) interval of < 70 ms and earliest atrial activation site (EAAS) in the proximal coronary sinus (pCS) include slow‐fast AVNRT with inferior deviation of the fast pathway (FP) and slow‐slow AVNRT with a lower common pathway (LCP). Therefore, we examined the electrophysiological and anatomical characteristics distinguishing slow‐fast AVNRT with inferior FP deviation from slow‐slow AVNRT with an LCP. Methods: Analyzed were 32 AVNRTs with HA intervals of < 70 ms and EAAS in pCS. During ablation at the EAAS, patients with atrio‐His (AH) interval prolongation leading to abandonment ( n = 7) were classified as slow‐fast AVNRT phenotype, while those with successful ablation without AH prolongation ( n = 25) were classified as slow‐slow AVNRT phenotype. Results: Triple antegrade AVN physiology, dual retrograde AVN physiology, and AH block during AVNRT were observed only in the slow‐slow AVNRT group. A ΔHA > 15 ms occurred more often in the slow‐slow AVNRT group (82% vs. 17%, p = 0.009). The AH VP ‐AH AVNRT —defined as the AH interval during right ventricular overdrive pacing minus that during AVNRT—was shorter in the slow‐slow AVNRT group (24 ± 24 vs. 1 ± 15 ms, p = 0.02). The His‐EAAS distance was shorter in the slow‐fast AVNRT group (7.3 ± 2.3 vs. 16.9 ± 4.9 mm, p < 0.001). Conclusion: In cases of AVNRT with an HA interval < 70 ms and EAAS in the pCS, the slow‐slow AVNRT phenotype is more prevalent than the slow‐fast AVNRT phenotype. The shorter AH VP ‐AH AVNRT and the His‐EAAS distance may help differentiate them.
- 1 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2241-2250
Accurate Diagnosis of Atrioventricular Nodal Reentrant Tachycardia With Very Short His‐Atrial Interval and Earliest Activation in the Proximal Coronary Sinus
Introduction: Differential diagnoses in atrioventricular nodal reentrant tachycardia (AVNRT) with His‐atrial (HA) interval of < 70 ms and earliest atrial activation site (EAAS) in the proximal coronary sinus (pCS) include slow‐fast AVNRT with inferior deviation of the fast pathway (FP) and slow‐slow AVNRT with a lower common pathway (LCP). Therefore, we examined the electrophysiological and anatomical characteristics distinguishing slow‐fast AVNRT with inferior FP deviation from slow‐slow AVNRT with an LCP. Methods: Analyzed were 32 AVNRTs with HA intervals of < 70 ms and EAAS in pCS. During ablation at the EAAS, patients with atrio‐His (AH) interval prolongation leading to abandonment ( n = 7) were classified as slow‐fast AVNRT phenotype, while those with successful ablation without AH prolongation ( n = 25) were classified as slow‐slow AVNRT phenotype. Results: Triple antegrade AVN physiology, dual retrograde AVN physiology, and AH block during AVNRT were observed only in the slow‐slow AVNRT group. A ΔHA > 15 ms occurred more often in the slow‐slow AVNRT group (82% vs. 17%, p = 0.009). The AH VP ‐AH AVNRT —defined as the AH interval during right ventricular overdrive pacing minus that during AVNRT—was shorter in the slow‐slow AVNRT group (24 ± 24 vs. 1 ± 15 ms, p = 0.02). The His‐EAAS distance was shorter in the slow‐fast AVNRT group (7.3 ± 2.3 vs. 16.9 ± 4.9 mm, p < 0.001). Conclusion: In cases of AVNRT with an HA interval < 70 ms and EAAS in the pCS, the slow‐slow AVNRT phenotype is more prevalent than the slow‐fast AVNRT phenotype. The shorter AH VP ‐AH AVNRT and the His‐EAAS distance may help differentiate them.
- Open Access
- 1 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (11) , 2587-2597
Large Language Model‐Based Localization of Premature Ventricular Contraction Origins: A Retrospective Diagnostic Accuracy Study
Background: Accurate localization of premature ventricular contraction (PVC) origin from 12‐lead electrocardiography (ECG) is important for procedural planning in catheter ablation. Although convolutional neural network (CNN)‐based models have shown promising diagnostic performance, they require task‐specific training and remain limited in interpretability. We evaluated whether large language model (LLM)‐based ECG image interpretation could perform binary left‐versus‐right PVC origin localization from 12‐lead ECG images while providing a traceable diagnostic process. Methods: We retrospectively studied 157 patients who underwent successful catheter ablation of PVCs or idiopathic ventricular tachycardia. ECG images were classified as RIGHT‐origin ( n = 103) or LEFT‐origin ( n = 54) according to the final successful ablation site. Three approaches were compared: a CNN‐based baseline model, an LLM‐based one‐shot approach, and an LLM‐based staged extraction framework with deterministic rule‐based integration. Performance was evaluated across five independent seeds using positive predictive value (PPV), negative predictive value (NPV), recall, and PPV + NPV. Results: The CNN‐based baseline model achieved a PPV of 0.546 ± 0.058 and an NPV of 0.793 ± 0.047, with area under the curve values ranging from 0.595 to 0.730. The staged extraction framework generated a continuous rule‐based score with discrimination numerically comparable to the CNN‐based model (AUC 0.720 ± 0.045 vs. 0.712 ± 0.054). A stricter threshold, determined from training data, increased PPV at the expense of recall and warrants prospective external validation of this operating point. Conclusions: LLM‐based staged extraction demonstrated the potential to achieve binary left‐versus‐right PVC origin localization from 12‐lead ECG images while providing a traceable stepwise diagnostic process. The continuous rule‐based score showed discrimination numerically comparable to the CNN‐based model, and the strict threshold—determined using training data—identified a potential high‐PPV operating point that requires prospective external validation.
- 1 August 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (11) , 2587-2597
Open AccessLarge Language Model‐Based Localization of Premature Ventricular Contraction Origins: A Retrospective Diagnostic Accuracy Study
Background: Accurate localization of premature ventricular contraction (PVC) origin from 12‐lead electrocardiography (ECG) is important for procedural planning in catheter ablation. Although convolutional neural network (CNN)‐based models have shown promising diagnostic performance, they require task‐specific training and remain limited in interpretability. We evaluated whether large language model (LLM)‐based ECG image interpretation could perform binary left‐versus‐right PVC origin localization from 12‐lead ECG images while providing a traceable diagnostic process. Methods: We retrospectively studied 157 patients who underwent successful catheter ablation of PVCs or idiopathic ventricular tachycardia. ECG images were classified as RIGHT‐origin ( n = 103) or LEFT‐origin ( n = 54) according to the final successful ablation site. Three approaches were compared: a CNN‐based baseline model, an LLM‐based one‐shot approach, and an LLM‐based staged extraction framework with deterministic rule‐based integration. Performance was evaluated across five independent seeds using positive predictive value (PPV), negative predictive value (NPV), recall, and PPV + NPV. Results: The CNN‐based baseline model achieved a PPV of 0.546 ± 0.058 and an NPV of 0.793 ± 0.047, with area under the curve values ranging from 0.595 to 0.730. The staged extraction framework generated a continuous rule‐based score with discrimination numerically comparable to the CNN‐based model (AUC 0.720 ± 0.045 vs. 0.712 ± 0.054). A stricter threshold, determined from training data, increased PPV at the expense of recall and warrants prospective external validation of this operating point. Conclusions: LLM‐based staged extraction demonstrated the potential to achieve binary left‐versus‐right PVC origin localization from 12‐lead ECG images while providing a traceable stepwise diagnostic process. The continuous rule‐based score showed discrimination numerically comparable to the CNN‐based model, and the strict threshold—determined using training data—identified a potential high‐PPV operating point that requires prospective external validation.
- Open Access
- 13 July 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (4)
Midterm Efficacy of SubcutAneous Implantable CardioVErter ‐Defibrillator in ≤ 18 Year‐Old CHILDREN ( SAVE CHILDREN ‐ II Registry)
Background: The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) avoids transvenous leads and is a promising option for sudden cardiac death (SCD) prevention in pediatric patients. However, mid‐term outcomes and post‐shock management strategies remain insufficiently characterized. Methods: This multicenter, retrospective observational study included pediatric patients (≤ 18 years) who underwent S‐ICD implantation between February 2016 and July 2021. Clinical characteristics, pre‐implant screening, procedural details, device‐related events, and follow‐up data were analyzed. The incidence and management of appropriate and inappropriate therapies and subsequent recurrence were evaluated. Results: Ninety‐six patients (median age 14.5 years) were enrolled and followed for a median of 70 months (29–75.0 months). Sensing vector suitability remained stable despite somatic growth. Appropriate shocks occurred in 32 patients (33.7%), while inappropriate shocks occurred in 27 (28.4%). After appropriate therapy, intensified pharmacological treatment and catheter ablation prevented recurrent device therapy in 45.5% and 50.0% of cases, respectively, although device shock occurred in 50.9% despite intervention. Following inappropriate therapy, device reprogramming and lifestyle guidance prevented recurrence in 71.4% of patients (15/21). Device‐related infection was rare (2 cases), and no lead fractures were observed. Conclusions: S‐ICD therapy demonstrated favorable mid‐term safety and efficacy in pediatric patients, with durable sensing performance and a low incidence of device‐related infection. Although inappropriate shocks were not uncommon, appropriate post‐shock management effectively reduced recurrence, supporting S‐ICD as a viable option for selected pediatric patients without pacing requirements.
- 13 July 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (4)
Open AccessMidterm Efficacy of SubcutAneous Implantable CardioVErter ‐Defibrillator in ≤ 18 Year‐Old CHILDREN ( SAVE CHILDREN ‐ II Registry)
Background: The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) avoids transvenous leads and is a promising option for sudden cardiac death (SCD) prevention in pediatric patients. However, mid‐term outcomes and post‐shock management strategies remain insufficiently characterized. Methods: This multicenter, retrospective observational study included pediatric patients (≤ 18 years) who underwent S‐ICD implantation between February 2016 and July 2021. Clinical characteristics, pre‐implant screening, procedural details, device‐related events, and follow‐up data were analyzed. The incidence and management of appropriate and inappropriate therapies and subsequent recurrence were evaluated. Results: Ninety‐six patients (median age 14.5 years) were enrolled and followed for a median of 70 months (29–75.0 months). Sensing vector suitability remained stable despite somatic growth. Appropriate shocks occurred in 32 patients (33.7%), while inappropriate shocks occurred in 27 (28.4%). After appropriate therapy, intensified pharmacological treatment and catheter ablation prevented recurrent device therapy in 45.5% and 50.0% of cases, respectively, although device shock occurred in 50.9% despite intervention. Following inappropriate therapy, device reprogramming and lifestyle guidance prevented recurrence in 71.4% of patients (15/21). Device‐related infection was rare (2 cases), and no lead fractures were observed. Conclusions: S‐ICD therapy demonstrated favorable mid‐term safety and efficacy in pediatric patients, with durable sensing performance and a low incidence of device‐related infection. Although inappropriate shocks were not uncommon, appropriate post‐shock management effectively reduced recurrence, supporting S‐ICD as a viable option for selected pediatric patients without pacing requirements.
- Open Access
- 30 June 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2173-2182
Clinical Utility of Tissue Proximity Indication With a Variable‐Loop Circular Catheter for Pulmonary Vein Isolation
Background: The variable‐loop circular catheter (VLCC, VARIPULSE) is a pulsed‐field ablation (PFA) catheter equipped with a Tissue Proximity Indication (TPI) function, which monitors catheter‐tissue contact. Although TPI‐negative sites have been reported to contribute to gap formation, no studies have evaluated the utility of real‐time function. This study assessed the success rate of pulmonary vein isolation (PVI) using the VLCC, incorporating the activated TPI function as the primary setting from the start of the procedure, representing an activated TPI function‐guided ablation approach. Methods: Between February 1 and September 3, 2025, 60 consecutive patients underwent PFA using the VLCC. After creating the 3D geometry using CARTOSOUND FAM before ablation, PVI using the VLCC was performed with the activated TPI function. After an initial two‐by‐two PFA set, the catheter orientation was adjusted to target areas without visible TPI‐positive tags. After applying an additional PFA application to ensure a circumferential TPI function‐on tags, a voltage map was created using a multielectrode catheter, and the rate of residual potentials was compared. Results: Using an activated TPI function‐guided PFA strategy, a first pass isolation was successfully achieved in 90% of patients (54/60) and in 97.1% of pulmonary veins (231/238). Multielectrode catheter mapping revealed residual antrum potentials in some cases, necessitating additional PFA applications in 3.8% of the pulmonary vein antrum (9/238). Conclusion: Activated TPI function‐guided PFA was associated with a low incidence of residual PV potentials, suggesting its potential utility to improve lesion continuity and procedural efficacy.
- 30 June 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (10) , 2173-2182
Open AccessClinical Utility of Tissue Proximity Indication With a Variable‐Loop Circular Catheter for Pulmonary Vein Isolation
Background: The variable‐loop circular catheter (VLCC, VARIPULSE) is a pulsed‐field ablation (PFA) catheter equipped with a Tissue Proximity Indication (TPI) function, which monitors catheter‐tissue contact. Although TPI‐negative sites have been reported to contribute to gap formation, no studies have evaluated the utility of real‐time function. This study assessed the success rate of pulmonary vein isolation (PVI) using the VLCC, incorporating the activated TPI function as the primary setting from the start of the procedure, representing an activated TPI function‐guided ablation approach. Methods: Between February 1 and September 3, 2025, 60 consecutive patients underwent PFA using the VLCC. After creating the 3D geometry using CARTOSOUND FAM before ablation, PVI using the VLCC was performed with the activated TPI function. After an initial two‐by‐two PFA set, the catheter orientation was adjusted to target areas without visible TPI‐positive tags. After applying an additional PFA application to ensure a circumferential TPI function‐on tags, a voltage map was created using a multielectrode catheter, and the rate of residual potentials was compared. Results: Using an activated TPI function‐guided PFA strategy, a first pass isolation was successfully achieved in 90% of patients (54/60) and in 97.1% of pulmonary veins (231/238). Multielectrode catheter mapping revealed residual antrum potentials in some cases, necessitating additional PFA applications in 3.8% of the pulmonary vein antrum (9/238). Conclusion: Activated TPI function‐guided PFA was associated with a low incidence of residual PV potentials, suggesting its potential utility to improve lesion continuity and procedural efficacy.
- Open Access
- 14 May 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (3)
Interlesion Time as a Key Metric of Procedural Proficiency in Atrial Fibrillation Ablation: From Fellow to Attending
Introduction: Pulmonary vein isolation (PVI) is a cornerstone of atrial fibrillation (AF) ablation. Unlike balloon‐based or pulsed field ablation, radiofrequency ablation requires precise catheter control and poses a steeper learning curve. This study aimed to compare technical parameters between attending and fellow electrophysiologists (EPs) using data extracted via cloud‐based analysis. Methods: A total of 194 patients undergoing first‐time AF ablation between April 2023 and September 2024 were analyzed. Procedural metrics, including contact force (CF), inter‐lesion time (ILT), and catheter stability, were compared across six anatomical regions between three attending and five fellow EPs. Results: Attending EPs achieved significantly shorter ILTs in PVI with moderate‐to‐large effect sizes (Attending vs. Fellows, sec; right PV, 4.8 [4.3–8.4] vs. 9.6 [5.5–15.6], p < 0.001, Hedges' g = −0.578; left PV, 6.7 [4.5–12.8] vs. 12.7 [6.9–21.7], p < 0.001, Hedges' g = −0.473), while CF and catheter stability showed smaller differences. In non‐PV regions such as the CTI and roof line, ILT differences were smaller, suggesting early skill acquisition in linear ablation areas by fellows. Discussion: ILT best reflected operator experience, with shorter ILTs likely contributing to improved lesion continuity and procedural proficiency. Fellows demonstrated comparable CF and catheter stability, potentially aided by steerable sheath use. Mastery of anatomical navigation may be key to advancing proficiency. Conclusion: Shorter ILTs by attending EPs reflect greater procedural proficiency. Emphasizing anatomical understanding and deliberate catheter manipulation during training may enhance skill development and improve clinical outcomes.
- 14 May 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (3)
Open AccessInterlesion Time as a Key Metric of Procedural Proficiency in Atrial Fibrillation Ablation: From Fellow to Attending
Introduction: Pulmonary vein isolation (PVI) is a cornerstone of atrial fibrillation (AF) ablation. Unlike balloon‐based or pulsed field ablation, radiofrequency ablation requires precise catheter control and poses a steeper learning curve. This study aimed to compare technical parameters between attending and fellow electrophysiologists (EPs) using data extracted via cloud‐based analysis. Methods: A total of 194 patients undergoing first‐time AF ablation between April 2023 and September 2024 were analyzed. Procedural metrics, including contact force (CF), inter‐lesion time (ILT), and catheter stability, were compared across six anatomical regions between three attending and five fellow EPs. Results: Attending EPs achieved significantly shorter ILTs in PVI with moderate‐to‐large effect sizes (Attending vs. Fellows, sec; right PV, 4.8 [4.3–8.4] vs. 9.6 [5.5–15.6], p < 0.001, Hedges' g = −0.578; left PV, 6.7 [4.5–12.8] vs. 12.7 [6.9–21.7], p < 0.001, Hedges' g = −0.473), while CF and catheter stability showed smaller differences. In non‐PV regions such as the CTI and roof line, ILT differences were smaller, suggesting early skill acquisition in linear ablation areas by fellows. Discussion: ILT best reflected operator experience, with shorter ILTs likely contributing to improved lesion continuity and procedural proficiency. Fellows demonstrated comparable CF and catheter stability, potentially aided by steerable sheath use. Mastery of anatomical navigation may be key to advancing proficiency. Conclusion: Shorter ILTs by attending EPs reflect greater procedural proficiency. Emphasizing anatomical understanding and deliberate catheter manipulation during training may enhance skill development and improve clinical outcomes.
- Open Access
- 7 May 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (3)
Feasibility and Safety of High‐Power Settings for Electrical Isolation of the Superior Vena Cava Using a Catheter Capable of Local Impedance and Contact Force Monitoring
Introduction: Recently, catheters incorporating both contact force (CF) sensing and local impedance (LI) measurement—an indicator of tissue temperature—have become clinically available. The present study aims to evaluate the efficacy of superior vena cava isolation (SVCI) using this catheter and to investigate the characteristics of impedance during the procedure. Methods: This retrospective study included 64 patients undergoing initial SVCI using the StablePoint catheter (40 W, CF 10–20 g, 8–10 s). We analyzed the success rate of SVCI and impedance data collected from 1 402 ablation points, with particular attention to the dynamics of LI and generator impedance (GI). Results: First‐pass isolation was achieved in all cases without complications such as phrenic nerve or sinus node injury. The LI drop was significantly greater and faster than the GI drop in all segments. The 90% decay time of LI was consistently 5–6 s, suggesting effective lesion formation during the resistive heating phase. LI provides a more reliable and localized indicator of tissue response than GI. The temporal profile of LI supports its utility in guiding safe and effective lesion delivery, particularly in the thin myocardial tissue of the SVC. Conclusion: High‐power ablation guided by LI and CF using the StablePoint catheter enables safe and effective SVCI with accurate real‐time assessment of lesion quality.
- 7 May 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (3)
Open AccessFeasibility and Safety of High‐Power Settings for Electrical Isolation of the Superior Vena Cava Using a Catheter Capable of Local Impedance and Contact Force Monitoring
Introduction: Recently, catheters incorporating both contact force (CF) sensing and local impedance (LI) measurement—an indicator of tissue temperature—have become clinically available. The present study aims to evaluate the efficacy of superior vena cava isolation (SVCI) using this catheter and to investigate the characteristics of impedance during the procedure. Methods: This retrospective study included 64 patients undergoing initial SVCI using the StablePoint catheter (40 W, CF 10–20 g, 8–10 s). We analyzed the success rate of SVCI and impedance data collected from 1 402 ablation points, with particular attention to the dynamics of LI and generator impedance (GI). Results: First‐pass isolation was achieved in all cases without complications such as phrenic nerve or sinus node injury. The LI drop was significantly greater and faster than the GI drop in all segments. The 90% decay time of LI was consistently 5–6 s, suggesting effective lesion formation during the resistive heating phase. LI provides a more reliable and localized indicator of tissue response than GI. The temporal profile of LI supports its utility in guiding safe and effective lesion delivery, particularly in the thin myocardial tissue of the SVC. Conclusion: High‐power ablation guided by LI and CF using the StablePoint catheter enables safe and effective SVCI with accurate real‐time assessment of lesion quality.
- Open Access
- 20 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2)
REgistry Of Catheter AbLation After Congenital Heart Disease Surgery( REAL ‐ CHD Registry)
Background: Advances in surgical management have improved long‐term survival in patients with congenital heart disease (CHD), leading to a growing population of adults with postoperative arrhythmias. However, contemporary data on catheter ablation practice and outcomes in patients with CHD remain limited. Methods: This multicenter, retrospective registry study included patients who underwent catheter ablation for postoperative CHD‐related arrhythmias between April 2007 and December 2025 at 10 centers. CHD severity was classified as mild, moderate, or severe according to Japanese Circulation Society guidelines. Procedural characteristics, arrhythmia profiles, acute procedural outcomes, and complications were analyzed. Associations between age, disease severity, arrhythmia burden, and procedural success were evaluated using regression analyses. Results: A total of 1 719 patients were included. The number of ablation procedures increased over time across all CHD severity categories. Increasing age was associated with lower disease severity, whereas patients with severe CHD, particularly those after a Fontan repair, underwent ablation at younger ages. Procedural success decreased with increasing CHD severity (complete success: 92.5% in mild, 81.4% in moderate, and 71.4% in severe CHD) and with a greater number of induced arrhythmia types. Overall, procedure‐related complications occurred in 2.3% of patients, with worsening heart failure being the most frequent non‐vascular adverse event. Conclusion: In a large contemporary Japanese cohort, catheter ablation for postoperative CHD‐related arrhythmias was increasingly performed and demonstrated acceptable safety. However, procedural success was lower in patients with more severe CHD and greater arrhythmia complexity, highlighting the need for specialized ablation strategies and careful periprocedural management in this growing population.
- 20 April 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (2)
Open AccessREgistry Of Catheter AbLation After Congenital Heart Disease Surgery( REAL ‐ CHD Registry)
Background: Advances in surgical management have improved long‐term survival in patients with congenital heart disease (CHD), leading to a growing population of adults with postoperative arrhythmias. However, contemporary data on catheter ablation practice and outcomes in patients with CHD remain limited. Methods: This multicenter, retrospective registry study included patients who underwent catheter ablation for postoperative CHD‐related arrhythmias between April 2007 and December 2025 at 10 centers. CHD severity was classified as mild, moderate, or severe according to Japanese Circulation Society guidelines. Procedural characteristics, arrhythmia profiles, acute procedural outcomes, and complications were analyzed. Associations between age, disease severity, arrhythmia burden, and procedural success were evaluated using regression analyses. Results: A total of 1 719 patients were included. The number of ablation procedures increased over time across all CHD severity categories. Increasing age was associated with lower disease severity, whereas patients with severe CHD, particularly those after a Fontan repair, underwent ablation at younger ages. Procedural success decreased with increasing CHD severity (complete success: 92.5% in mild, 81.4% in moderate, and 71.4% in severe CHD) and with a greater number of induced arrhythmia types. Overall, procedure‐related complications occurred in 2.3% of patients, with worsening heart failure being the most frequent non‐vascular adverse event. Conclusion: In a large contemporary Japanese cohort, catheter ablation for postoperative CHD‐related arrhythmias was increasingly performed and demonstrated acceptable safety. However, procedural success was lower in patients with more severe CHD and greater arrhythmia complexity, highlighting the need for specialized ablation strategies and careful periprocedural management in this growing population.
- Open Access
- 11 April 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (6) , 1249-1258
Comparison of HEMOlysis Markers Among Three Pulsed Field Ablation Systems: HEMO‐PFA Study
Background: Pulsed field ablation (PFA) has emerged as a novel non‐thermal modality for atrial fibrillation (AF) ablation. While hemolysis is a known complication of PFA, comparative data among different systems remain limited. Methods: We prospectively enrolled 150 consecutive AF patients undergoing ablation with one of three PFA systems: FARAPULSE (FP), PulseSelect (PS), or VARIPULSE (VP) (50 cases each). Perioperative blood samples were collected pre‐procedure, immediately post‐procedure, and at 24 h. Hemolysis markers (LDH, LD2, indirect bilirubin, haptoglobin) and myocardial injury markers (CK, CK‐MB, troponin T) were measured. Procedural characteristics and complications were compared across the systems. Results: Among 144 analyzed patients, VP was associated with the shortest procedure time (76 ± 27 min vs. FP 91 ± 25 min and PS 97 ± 26 min, p < 0.001) and fewest applications (23 ± 5 vs. FP 40 ± 6 and PS 56 ± 26, p < 0.001). Hemolysis markers increased in all systems, but the magnitude varied. ΔLDH was highest with FP (95.1 ± 49.4 U/L), intermediate with PS (62.6 ± 38.1 U/L), and lowest with VP (41.3 ± 26.7 U/L; p < 0.001). Haptoglobin decreased most with FP (ΔHp −56.5 ± 27.2 mg/dL), followed by VP (−41.7 ± 25.8 mg/dL) and PS (−28.3 ± 21.6 mg/dL; p < 0.001). Myocardial injury also differed: ΔTroponin T was lowest with VP (1545 ± 920 pg/mL vs. FP 2392 ± 1123 pg/mL and PS 2128 ± 1041 pg/mL, p = 0.002), with a similar trend for ΔCK (141 ± 92 U/L vs. 231 ± 138 U/L and 207 ± 119 U/L, p < 0.001). Complications included acute kidney injury in two FP cases and cardiac tamponade in one PS case. Conclusions: Hemolysis and myocardial injury differ among PFA systems. FP was associated with the greatest changes, PS with the least hemolysis, and VP with the least myocardial injury. These differences may reflect variations in pulse output, electrode configuration, and tissue contact visualization.
- 11 April 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (6) , 1249-1258
Open AccessComparison of HEMOlysis Markers Among Three Pulsed Field Ablation Systems: HEMO‐PFA Study
Background: Pulsed field ablation (PFA) has emerged as a novel non‐thermal modality for atrial fibrillation (AF) ablation. While hemolysis is a known complication of PFA, comparative data among different systems remain limited. Methods: We prospectively enrolled 150 consecutive AF patients undergoing ablation with one of three PFA systems: FARAPULSE (FP), PulseSelect (PS), or VARIPULSE (VP) (50 cases each). Perioperative blood samples were collected pre‐procedure, immediately post‐procedure, and at 24 h. Hemolysis markers (LDH, LD2, indirect bilirubin, haptoglobin) and myocardial injury markers (CK, CK‐MB, troponin T) were measured. Procedural characteristics and complications were compared across the systems. Results: Among 144 analyzed patients, VP was associated with the shortest procedure time (76 ± 27 min vs. FP 91 ± 25 min and PS 97 ± 26 min, p < 0.001) and fewest applications (23 ± 5 vs. FP 40 ± 6 and PS 56 ± 26, p < 0.001). Hemolysis markers increased in all systems, but the magnitude varied. ΔLDH was highest with FP (95.1 ± 49.4 U/L), intermediate with PS (62.6 ± 38.1 U/L), and lowest with VP (41.3 ± 26.7 U/L; p < 0.001). Haptoglobin decreased most with FP (ΔHp −56.5 ± 27.2 mg/dL), followed by VP (−41.7 ± 25.8 mg/dL) and PS (−28.3 ± 21.6 mg/dL; p < 0.001). Myocardial injury also differed: ΔTroponin T was lowest with VP (1545 ± 920 pg/mL vs. FP 2392 ± 1123 pg/mL and PS 2128 ± 1041 pg/mL, p = 0.002), with a similar trend for ΔCK (141 ± 92 U/L vs. 231 ± 138 U/L and 207 ± 119 U/L, p < 0.001). Complications included acute kidney injury in two FP cases and cardiac tamponade in one PS case. Conclusions: Hemolysis and myocardial injury differ among PFA systems. FP was associated with the greatest changes, PS with the least hemolysis, and VP with the least myocardial injury. These differences may reflect variations in pulse output, electrode configuration, and tissue contact visualization.
- Open Access
- 16 February 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (1)
Intracardiac Echocardiography–Guided Implantation of Aveir VR Leadless Pacemaker
Intracardiac echocardiography (ICE) enabled safe, contrast‐free implantation of an Aveir VR leadless pacemaker in a high‐risk patient with severe contrast allergy and prior device infection, allowing real‐time assessment of right ventricular anatomy and myocardial wall thickness to minimize perforation risk.
- 16 February 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (1)
Open AccessIntracardiac Echocardiography–Guided Implantation of Aveir VR Leadless Pacemaker
Intracardiac echocardiography (ICE) enabled safe, contrast‐free implantation of an Aveir VR leadless pacemaker in a high‐risk patient with severe contrast allergy and prior device infection, allowing real‐time assessment of right ventricular anatomy and myocardial wall thickness to minimize perforation risk.